Studies Warn of NuvaRing Blood Clots as Lawsuits Grow

The NuvaRing Center is the Web’s largest source for information on NuvaRing research, side effects and legal news. Visit http://www.NuvaRing-Lawsuits.net

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
nuvaring lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after using NuvaRing is urged to contact the NuvaRing Resource Center or speak with a lawyer about their legal options.

Orlando, FL (PRWEB) August 17, 2012

The NuvaRing Resource Center, a patient advocacy group, is alerting women who used the contraceptive NuvaRing that European researchers and the FDA have warned the device may be linked to increased risks of blood clots and related injuries. Lawyers are currently helping those affected determine their legal options.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after using NuvaRing is urged to contact the NuvaRing Resource Center or speak with a lawyer about their legal options.

NuvaRing is a once-a-month vaginal ring contraceptive which Merck marketed as containing lower doses of hormones. However, the device releases chemicals directly into the bloodstream on a constant basis.

The FDA has received over 1,000 reports of blood clot injury or death in patients using NuvaRing. On October 27, 2011 they released a report titled, "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints", which showed vaginal ring contraceptives could increase the risks of blood clots by as much as 56% over traditional birth control pills.

The British Medical Journal published a study from Denmark on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a Danish study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.

Due to the large number of NuvaRing lawsuits filed by patients, a federal panel established a Multi-District Litigation court in Missouri to handle the claims. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. So far, nearly 1,000 patients have filed a claim.

The NuvaRing Resource Center urges anyone affected by blood clots, stroke, DVT or pulmonary embolism after using NuvaRing to learn their legal rights as soon as possible. Victims should make sure they choose a lawyer with experience in defective drug litigation. The Resource Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on research, side effects and litigation news related to NuvaRing devices, or to speak with a lawyer, visit http://www.NuvaRing-Lawsuits.net


Contact